Histology
Carcinoma of Unknown Primary
CI-CAN-00002109Explore in graph →
4,156 active trials54 approved drugs532 evidence items
Loading cancer entity…
Histology
CI-CAN-00002109Explore in graph →
Clinical trials
14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,893)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00518557 | Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis(TACE HCC) | unknown | N/A | 60 | Southeast University, ChinaOTHER | 1 | Jan 22, 2009 | clinicaltrials |
| NCT00116610 | Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer | completed | Phase 2 | 75 | Poniard PharmaceuticalsINDUSTRY | 3 | Jan 21, 2009 | clinicaltrials |
| NCT00216801 | Relationship of Ochratoxin A to Upper Urologic Cancers | completed | — | 60 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00496301 | Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC(SOGUG-02-06) | completed | Phase 2 | 40 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00637364 | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain(HIFU Pancreas) | suspended | Phase 1 / Phase 2 | 5 | CMED HIFU Development CorporationINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00805896 | Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma | unknown | Phase 2 | 260 | Fudan UniversityOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00290953 | Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide(SESAME) | completed | Phase 2 / Phase 3 | 432 | SanofiINDUSTRY | 14 | Dec 23, 2008 | clinicaltrials |
| NCT00444782 | A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. | completed | Phase 2 | 41 | Pharmexa A/SINDUSTRY | 3 | Dec 18, 2008 | clinicaltrials |
| NCT00319683 | A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma | terminated | Phase 1 / Phase 2 | — | Adherex Technologies, Inc.INDUSTRY | 3 | Dec 15, 2008 | clinicaltrials |
| NCT00165633 | A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma | terminated | Phase 2 / Phase 3 | 540 | Eisai LimitedINDUSTRY | 1 | Dec 9, 2008 | clinicaltrials |
| NCT00797251 | Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression | unknown | — | 10 | University of MilanOTHER | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00556803 | TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma(TACE-RFA) | unknown | Phase 4 | 120 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00557024 | Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(RT-RFA) | unknown | Phase 4 | 80 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00377936 | EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas | completed | Phase 2 | 212 | MediGeneINDUSTRY | 3 | Nov 14, 2008 | clinicaltrials |
| NCT00421512 | A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients | completed | Phase 1 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 11, 2008 | clinicaltrials |
| NCT00230139 | SPECT/CT in Endocrine and Neuroendocrine Tumors | completed | N/A | 200 | Rambam Health Care CampusOTHER | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00178867 | A National Registry of Patients With Hepatocellular Carcinoma | completed | — | 150 | Vanderbilt UniversityOTHER | 1 | Oct 10, 2008 | clinicaltrials |
| NCT00770393 | Laryngeal Preservation in Pyriform Sinus Carcinoma | completed | Phase 2 / Phase 3 | 71 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Oct 10, 2008 | clinicaltrials |
| NCT00669747 | Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | unknown | Phase 2 | 45 | Windy Hill Medical, Inc.INDUSTRY | 1 | Oct 2, 2008 | clinicaltrials |
| NCT00764166 | A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel(RisingPSA) | unknown | Phase 3 | 254 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 1, 2008 | clinicaltrials |
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00752063 | Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma(SECOX) | unknown | Phase 2 | 52 | The University of Hong KongOTHER | 1 | Sep 15, 2008 | clinicaltrials |
| NCT00546130 | Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer(RNCLC) | unknown | Phase 2 | 45 | University of ToyamaOTHER | 1 | Sep 3, 2008 | clinicaltrials |
| NCT00415155 | A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma | withdrawn | Phase 1 / Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 4 | Aug 29, 2008 | clinicaltrials |
| NCT00351195 | Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 2 | 39 | Rigshospitalet, DenmarkOTHER | 1 | Aug 26, 2008 | clinicaltrials |
| NCT00129844 | Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | completed | Phase 2 | 108 | Pharmacyclics LLC.INDUSTRY | 2 | Aug 20, 2008 | clinicaltrials |
| NCT00239200 | Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus | terminated | Phase 2 | 29 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 30, 2008 | clinicaltrials |
| NCT00056693 | Treatment With SU11248 in Patients With Neuroendocrine Tumors | completed | Phase 2 | 107 | PfizerINDUSTRY | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00422786 | Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 10 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00697814 | Clomiphene in Males With Prolactinomas and Persistent Hypogonadism | completed | Phase 2 | 15 | Federal University of São PauloOTHER | 1 | Jun 16, 2008 | clinicaltrials |
| NCT00298688 | A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer | completed | Phase 2 | 56 | AstraZenecaINDUSTRY | 2 | Jun 12, 2008 | clinicaltrials |
| NCT00636259 | Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer | no longer available | — | — | AstraZenecaINDUSTRY | 0 | Jun 11, 2008 | clinicaltrials |
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 0 | Jun 4, 2008 | clinicaltrials |
| NCT00139230 | Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00687778 | 11C-Acetate PET/CT Non-FDG-Avid Tumors | unknown | — | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00679692 | Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease | completed | — | 210 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | May 19, 2008 | clinicaltrials |
| NCT00168987 | Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors | completed | Phase 4 | 30 | Charite University, Berlin, GermanyOTHER | 1 | May 9, 2008 | clinicaltrials |
| NCT00440934 | A Study of Electromagnetic Waves in the Treatment of the Advanced Hepatocarcinoma(THBC002) | terminated | Phase 2 | 0 | Pasche, Boris, M.D.INDIV | 1 | May 6, 2008 | clinicaltrials |
| NCT00662168 | An Investigation of Small Intestinal Carcinoid Carcinoma in Families | unknown | — | 8 | Rutgers UniversityOTHER | 1 | Apr 21, 2008 | clinicaltrials |
| NCT00460616 | Cardiac Valve Complications in Prolactinomas Treated With Cabergoline(ValveCab) | completed | — | 50 | Federico II UniversityOTHER | 1 | Apr 16, 2008 | clinicaltrials |
| NCT00652613 | Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | unknown | Phase 2 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00095186 | Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00635323 | Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma | completed | Phase 2 | 73 | PfizerINDUSTRY | 4 | Apr 7, 2008 | clinicaltrials |
| NCT00461344 | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer | terminated | Phase 2 | 20 | SanofiINDUSTRY | 0 | Apr 3, 2008 | clinicaltrials |
| NCT00652587 | Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma | completed | Phase 3 | 115 | Sun Yat-sen UniversityOTHER | 1 | Apr 3, 2008 | clinicaltrials |
| NCT00041613 | Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate | unknown | Phase 3 | — | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00384124 | Topical Imiquimod for Bowen's Disease of the Head and Neck | unknown | Phase 2 / Phase 3 | 50 | Brooke Army Medical CenterFED | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00644020 | Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients | unknown | — | 100 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Jan 22, 2009source: clinicaltrials